Octadecyl methacrylate | CAS:32360-05-7

We serve Octadecyl methacrylate CAS:32360-05-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Octadecyl methacrylate

Chemical Name:Octadecyl methacrylate
CAS.NO:32360-05-7
Synonyms:Octadecyl methacrylate
N-STEARYL METHACRYLATE
METHACRYLIC ACID STEARYL ESTER
Stearyl Methylacrylate
octadecylmethacrylate
Molecular Formula:C22H42O2
Molecular Weight:338.56800
 
Physical and Chemical Properties:
Density:0.864
Melting point:18-20ºC
Boiling point:195ºC
Flash point:>230°F
Index of Refraction:1.451
 
Specification:
Appearance:Yellow transparent liquid
Assay:≥99.0%
Chromaticity:≤80 APHA
Moisture:≤0.2%
Acid value:≤0.3
MEHQ:150-250 ppm
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:A kind of long chain alkyl acrylate which enable it’s down stream polymer owns good hydrophobic & oleophylic properties. It could be used for the synthesis of various chemical compound such as crude oil pour point depressant, fabric waterproofing agent & oil proofing agent, waterproofing agent for leather, oil absorption resin. It could also be used for the modification of polymer in the ink, paint and adhesive industries.



Contact us for information like Octadecyl methacrylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,octadecylmethacrylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Stearyl Methylacrylate Use and application,octadecylmethacrylate technical grade,usp/ep/jp grade.


Related News: “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”2-Bromobutyric acid manufacturer The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.6-Oxo-1,6-dihydro-3-pyridazinecarboxamide supplier Both patients were being treated in isolation units at a Manila hospital.dibenzofuran-4,6-bis-(boronic acid) vendor There’s still a lot we don’t know about the coronavirus, and scientists internationally are racing to gather data and develop a treatment.The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.